---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-013779"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2022-05-16T23:59:59+00:00"
generated_at: "2026-06-25T14:42:07.578127+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# MariMed Q1 revenue up 27% to $31.3M; adj EBITDA $10.4M, guidance reaffirmed

## Summary
- Revenue $31.3M (up 27% YoY); gross margin 54.3% vs 53.5%; net income $4.2M (flat YoY).
- Non-GAAP adjusted EBITDA $10.4M (+29% YoY); cash from operations $8.5M; working capital $20.1M.
- Closed Maryland and Illinois acquisitions post-quarter; plans CSE listing to boost liquidity.
- FY 2022 guidance held: revenue $145-150M, gross margin 54-55%, adj EBITDA $47-52M, capex ~$25M.
- Retail dispensary revenue grew 41% YoY; wholesale up 6%; launched THC-infused drink mixes in MA.

## SEC filing metadata
- accession: 0001493152-22-013779
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2022-05-16T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000149315222013779/0001493152-22-013779-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000149315222013779/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-013779
- JSON: https://secwatch.observer/filing/0001493152-22-013779.json
- Plain text: https://secwatch.observer/filing/0001493152-22-013779.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.